Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
Mexico says a third of 130,000 missing people might be alive, fueling criticisms by families- Former 'Bachelorette' welcomes 1st baby via emergency c-section
- Four new luxury hotel openings in Italy you need to know about
- Would you ever turn to AI for companionship? 6% of Americans say they could — or already have.
- Fascinating Fishing Objections From Around The World
- Brazil approves law strengthening protective measures for female victims of gender-based violence
- 4 astronauts depart ISS, leaving behind just 3 crewmates to staff the orbiting lab
- NASA releases stunning first images of Earth taken by the Artemis II astronauts
- Earthquake in Indonesia kills at least 1 person and sets off small tsunami
